Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
JH

Jens Hoffmann — 16 Patents

SCSchering: 9 patents #342 of 2,442Top 15%
BABayer Schering Pharma Ag: 4 patents #56 of 464Top 15%
BGBayer Intellectual Property Gmbh: 1 patents #640 of 1,266Top 55%
Hoffmann-La Roche: 1 patents #1,850 of 3,238Top 60%
SLSterix Limited: 1 patents #29 of 52Top 60%
Mühlenbeck, DE: #1 of 1 inventorsTop 100%
Overall (All Time): #284,196 of 4,157,543Top 7%
16 Patents All Time
Jens Hoffmann has been granted 16 US patents while listed as an inventor at Schering. The first was granted in 2004 and the most recent in November 2020. Jens Hoffmann ranks #284,196 of 4,157,543 US inventors in our database (top 6.8%). Patent records list Jens Hoffmann in Mühlenbeck, DE.

Issued Patents All Time

Showing 1–16 of 16 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10837042 Feed mixing device and its use Sylvia Baumann, Alexander Jockwer, Christian Klinger, Thomas Troebs 2020-11-17
8524722 Substituted tricyclic compounds and methods of use thereof Hartmut Schirok, Ying Li-Sommer, Michael Brands, Mario Lobell, Adrian Tersteegen +8 more 2013-09-03
8026229 Antitumor-active 2-alkoxyestradiol sulfamates Ina Scherlitz-Hofmann, Alexander Hillisch, Eberhard Unger, Tobias Neumann, Sigfrid Schwarz +2 more 2011-09-27
7700621 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations Ulrich Klar, Wolfgang Schwede, Werner Skuballa, Bernd Buchmann, Rosemarie Lichtner 2010-04-20
7645891 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations Ulrich Klar, Wolfgang Schwede, Werner Skuballa, Bernd Buchmann, Rosemarie Lichtner 2010-01-12
7605136 Effector conjugates, methods for their preparation and their pharmaceutical use Klaus Bosslet, Holger Hess-Stumpp, Ulrich Klar, Andrea Rotgeri 2009-10-20
7538100 17α-alkyl-17β-oxy-estratrienes and intermediate products for their production, use of the 17α-alkyl-17β-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations Rolf Bohlmann, Nikolaus Heinrich, Rolf Jautelat, Jorg Kroll, Orlin Petrov +2 more 2009-05-26
7378406 Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases Rosemarie Lichtner, Gerhard Siemeister, Martin Schneider, Ulrike Fuhrmann 2008-05-27
7125893 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations Ulrich Klar, Wolfgang Schwede, Werner Skuballa, Bernd Buchmann, Rosemarie Lichtner 2006-10-24 $370,000
7119082 11β-long-chain-substituted 19-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring Gerd Mueller, Karl-Heinrich Fritzemeier, Alexander Hillisch 2006-10-10 $726,000
7018994 17α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, USE OF THE 17α-ALKYL-17β-OXY-ESTRATRIENES FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS AS WELL AS PHARMACEUTICAL PREPARATIONS Rolf Bohlmann, Nikolaus Heinrich, Rolf Jautelat, Jorg Kroll, Orlin Petrov +2 more 2006-03-28 $6,546,000
6956031 11β-Substituted 19-nor-17-α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring Alexander Hillisch, Walter Elger, Rolf Bohlmann 2005-10-18 $2,704,000
6861432 Piperazine derivatives that destabilize androgen receptors Arwed Cleve, Christoph Huwe, Volker Schulze, Helmut Morack, Dieter Zopf +1 more 2005-03-01 $1,045,000
6790842 11&bgr; LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11&bgr; LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS Rolf Bohlmann, Nikolaus Heinrich, Jorg Kroll, Gerhard Sauer, Karl-Heinrich Fritzemeier +3 more 2004-09-14 $472,000
6767903 New7&agr;, 17&agr;-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases Arwed Cleve, Gerhard Sauer, Christoph Huwe, Karsten Parczyk, Martin Schneider 2004-07-27 $1,881,000
6747046 Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents Martin Kruger, Olaf Prien, Andreas Steinmeyer, Jorg Kroll, Alexander Ernst +2 more 2004-06-08 $731,000